BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7107070)

  • 1. Corynebacterium parvum prevents immunization to admixed irradiated tumor cells by a local process.
    Titus MJ; Bartlett GL; Kreider JW
    Int J Cancer; 1982 Jun; 29(6):699-705. PubMed ID: 7107070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active, specific immunotherapy of murine leukemia. II. Adjuvant effect of Corynebacterium parvum.
    Bartlett GL; Kreider JW
    Int J Cancer; 1979 Nov; 24(5):636-43. PubMed ID: 528079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
    Bartlett GL; Kreider JW; Purnell DM
    Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of purified cell walls from Corynebacterium parvum.
    Riveros-Moreno V; Bomford R; Scott MT
    J Natl Cancer Inst; 1978 Mar; 60(3):653-8. PubMed ID: 625069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to transplantable nitrosourea-induced neurogenic tumors. I. Potentiation of tumor immunity with Corynebacterium parvum.
    Cravioto HM; DeBernardo E; Hochwald GM; Thorbecke JG
    J Neuropathol Exp Neurol; 1981 Sep; 40(5):526-36. PubMed ID: 7276992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific T-lymphocyte cytotoxicity enhanced by low dose of C. parvum.
    Lau BH; Wang-Cheng RM; Tosk J
    J Leukoc Biol; 1987 May; 41(5):407-11. PubMed ID: 3494802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
    Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
    Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between intradermal tumor suppression and tumor immunity.
    Bartlett GL; Kreider JW; Purnell DM
    J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.
    Dye ES; North RJ; Mills CD
    J Exp Med; 1981 Sep; 154(3):609-20. PubMed ID: 6974214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of the tumor-specific immune response by Corynebacterium parvum.
    Scott MT
    J Natl Cancer Inst; 1975 Jul; 55(1):65-72. PubMed ID: 808637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Corynebacterium parvum on murine myeloid leukaemia.
    Bjornsson S; Preisler H; Pavelic Z
    Br J Cancer; 1978 Dec; 38(6):703-8. PubMed ID: 217398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of C. parvum and specific immunization against artificial pulmonary metastases in mice.
    Milas L; Kogelnik HD; Basic I; Mason K; Hunter N; Withers HR
    Int J Cancer; 1975 Nov; 16(5):738-46. PubMed ID: 1184241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.
    Smith SE; Scott MT
    Br J Cancer; 1972 Oct; 26(5):361-7. PubMed ID: 4343677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor immunity induced by hybrid murine tumor cells: requirements for optimal immunization.
    McCune CS; O'Donnell RW; Horan PK; Budd HS; Spennacchio JL; Chuang C; Henshaw EC
    J Natl Cancer Inst; 1982 Sep; 69(3):647-52. PubMed ID: 6955557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression.
    Mills CD; North RJ; Dye ES
    J Exp Med; 1981 Sep; 154(3):621-30. PubMed ID: 6974215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
    Shu SY; Chou T; Sakai K
    J Immunol; 1989 Jul; 143(2):740-8. PubMed ID: 2738408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.
    Woodruff MF; Warner NL
    J Natl Cancer Inst; 1977 Jan; 58(1):111-6. PubMed ID: 299893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopotentiation of cell-mediated hypersensitivity by Corynebacterium parvum (Propionibacterium acnes).
    Maguire HC; Cipriano D
    Int Arch Allergy Appl Immunol; 1983; 70(1):34-9. PubMed ID: 6848475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
    Reif AE
    Cancer Res; 1985 Jan; 45(1):25-31. PubMed ID: 3965136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.